MINK1 Kinase Suppresses TH17 Differentiation and Autoimmune Inflammation Via Inhibition of the TGF-β Pathway

Linrong Lu
DOI: https://doi.org/10.4049/jimmunol.196.supp.58.16
2016-01-01
The Journal of Immunology
Abstract:Abstract TH17 cells (interleukin-17-producing helper T cells) are present at the sites of tissue inflammation and associated with the induction of multiple autoimmune diseases. The differentiation of TH17 cells is instructed and critically regulated by various cytokines in the microenvironment, which drive intracellular signaling pathways and transcription profiles that determine the cell fate. Here we show that MINK1, a germinal center kinase (GCK) family kinase, plays as a negative regulator for TH17 cell differentiation. Mink1−/− mice has higher frequency of TH17 cells in vivo and developed more severe experimental autoimmune encephalomyelitis (EAE) than wild type (WT) mice. Further experiments revealed that MINK1 directly interacts with SMAD2 and phosphorylates SAMD2 at T324 residue in its α-helix 1 region, which inhibits the C-terminal phosphorylation (activation) of SMAD2. Moreover, we found that MINK1 kinase is activated by T cell receptor stimulation in a ROS (reactive oxygen species)-dependent manner, which can be compromised by ROS scavenger N-acetyl cysteine (NAC). Accordingly, NAC treatment markedly boost the in vitro induction of TH17 cells in a MINK1-dependent manner and potentiates TH17 cells generation and development of EAE in vivo. In sum, our data not only demonstrate a regulatory role of MINK1 kinase in TH17 cell differentiation, but also provide the molecular insight into a possible mechanism, by which increased dietary antioxidants supplement might represent a health risk factor for the development of autoimmune diseases through increased induction of TH17 cells.
What problem does this paper attempt to address?